LDHA and cancer: Furthermore, the activity of aldehyde dehydrogenase (ALDH), a marker of cancer stem-cells, was increased by paclitaxel in HMLER cells by 1.27-fold and this effect was lost with knock-down of SNAI1 (Figure 5D).